Immunosuppression Regimen Use and Outcomes in Older and Younger Adult Kidney Transplant Recipients: A National Registry Analysis

Overview

Journal Transplantation

Specialty General Surgery

Date 2020 Nov 20

PMID 33214534

Citations 11

Authors

Krista L Lentine

Wisit Cheungpasitporn

Huiling Xiao

Mara McAdams-DeMarco

Ngan N Lam

Dorry L Segev

Sunjae Bae

JiYoon B Ahn

Gregory P Hess

Yasar Caliskan

Henry B Randall

Bertram L Kasiske

Mark A Schnitzler

David A Axelrod

Affiliations

Soon will be listed here.

Abstract

Background: Although the population of older transplant recipients has increased dramatically, there are limited data describing the impact of immunosuppression regimen choice on outcomes in this recipient group.

Methods: National data for US Medicare-insured adult kidney recipients (N = 67 362; 2005-2016) were examined to determine early immunosuppression regimen and associations with acute rejection, death-censored graft failure, and mortality using multivariable regression analysis in younger (18-64 y) and older (>65 y) adults.

Results: The use of antithymocyte globulin (TMG) or alemtuzumab (ALEM) induction with triple maintenance immunosuppression (reference) was less common in older compared with younger (36.9% versus 47.0%) recipients, as was TMG/ALEM + steroid avoidance (19.2% versus 20.1%) and mammalian target of rapamycin inhibitor (mTORi)-based (6.7% versus 7.7%) treatments. Conversely, older patients were more likely to receive interleukin (IL)-2-receptor antibody (IL2rAb) + triple maintenance (21.1% versus 14.7%), IL2rAb + steroid avoidance (4.1% versus 1.8%), and cyclosporine-based (8.3% versus 6.6%) immunosuppression. Compared with older recipients treated with TMG/ALEM + triple maintenance (reference regimen), those managed with TMG/ALEM + steroid avoidance (adjusted odds ratio [aOR], 0.440.520.61) and IL2rAb + steroid avoidance (aOR, 0.390.550.79) had lower risk of acute rejection. Older patients experienced more death-censored graft failure when managed with Tac + antimetabolite avoidance (adjusted hazard [aHR], 1.411.782.25), mTORi-based (aHR, 1.702.142.71), and cyclosporine-based (aHR, 1.411.782.25) regimens, versus the reference regimen. mTORi-based and cyclosporine-based regimens were associated with increased mortality in both older and younger patients.

Conclusions: Lower-intensity immunosuppression regimens (eg, steroid-sparing) appear beneficial for older kidney transplant recipients, while mTORi and cyclosporine-based maintenance immunosuppression are associated with higher risk of adverse outcomes.

Citing Articles

Early Steroid Withdrawal in Kidney Transplant Recipients: PRO.

Virmani S, Asch W Kidney360. 2025; 6(2):191-193.

PMID: 40014439 PMC: 11882247. DOI: 10.34067/KID.0000000000000326.

Gut Microbial Dysbiosis and Implications in Solid Organ Transplantation.

Medina C, Aykut B Biomedicines. 2025; 12(12.

PMID: 39767699 PMC: 11673786. DOI: 10.3390/biomedicines12122792.

Safety and Efficacy of a Preemptive Mycophenolate Mofetil Dose Reduction Strategy in Kidney Transplant Recipients.

Yatim K, Al Jurdi A, El Mouhayyar C, Morena L, Hullekes F, Verhoeff R Transplant Direct. 2024; 10(9):e1697.

PMID: 39220216 PMC: 11365660. DOI: 10.1097/TXD.0000000000001697.

Perioperative Considerations in Older Kidney and Liver Transplant Recipients: A Review.

Chanan E, Wagener G, Whitlock E, Berger J, McAdams-DeMarco M, Yeh J Transplantation. 2024; 108(11):e346-e356.

PMID: 38557579 PMC: 11442682. DOI: 10.1097/TP.0000000000005000.

Kidney transplants from elderly donors: what we have learned 20 years after the Crystal City consensus criteria meeting.

Mella A, Calvetti R, Barreca A, Congiu G, Biancone L J Nephrol. 2024; 37(6):1449-1461.

PMID: 38446386 PMC: 11473582. DOI: 10.1007/s40620-024-01888-w.

References

Meier-Kriesche H, Friedman G, Jacobs M, Mulgaonkar S, Vaghela M, Kaplan B . Infectious complications in geriatric renal transplant patients: comparison of two immunosuppressive protocols. Transplantation. 1999; 68(10):1496-502. DOI: 10.1097/00007890-199911270-00012. View

Lentine K, Gheorghian A, Axelrod D, Kalsekar A, LItalien G, Schnitzler M . The implications of acute rejection for allograft survival in contemporary U.S. kidney transplantation. Transplantation. 2012; 94(4):369-76. DOI: 10.1097/TP.0b013e318259407f. View

Hart A, Smith J, Skeans M, Gustafson S, Wilk A, Castro S . OPTN/SRTR 2018 Annual Data Report: Kidney. Am J Transplant. 2020; 20 Suppl s1:20-130. DOI: 10.1111/ajt.15672. View

Jacobson P, Schladt D, Oetting W, Leduc R, Guan W, Matas A . Lower calcineurin inhibitor doses in older compared to younger kidney transplant recipients yield similar troughs. Am J Transplant. 2012; 12(12):3326-36. PMC: 3513646. DOI: 10.1111/j.1600-6143.2012.04232.x. View

Kalble T, Lucan M, Nicita G, Sells R, Burgos Revilla F, Wiesel M . EAU guidelines on renal transplantation. Eur Urol. 2005; 47(2):156-66. DOI: 10.1016/j.eururo.2004.02.009. View

Pascual J, Galeano C, Royuela A, Zamora J . A systematic review on steroid withdrawal between 3 and 6 months after kidney transplantation. Transplantation. 2010; 90(4):343-9. DOI: 10.1097/TP.0b013e3181e58912. View

Knoll G . Kidney transplantation in the older adult. Am J Kidney Dis. 2012; 61(5):790-7. DOI: 10.1053/j.ajkd.2012.08.049. View

Stevens L, Viswanathan G, Weiner D . Chronic kidney disease and end-stage renal disease in the elderly population: current prevalence, future projections, and clinical significance. Adv Chronic Kidney Dis. 2010; 17(4):293-301. PMC: 3160131. DOI: 10.1053/j.ackd.2010.03.010. View

Oniscu G, Brown H, Forsythe J . Impact of cadaveric renal transplantation on survival in patients listed for transplantation. J Am Soc Nephrol. 2005; 16(6):1859-65. DOI: 10.1681/ASN.2004121092. View

10.

Saran R, Robinson B, Abbott K, Agodoa L, Bragg-Gresham J, Balkrishnan R . US Renal Data System 2018 Annual Data Report: Epidemiology of Kidney Disease in the United States. Am J Kidney Dis. 2019; 73(3 Suppl 1):A7-A8. PMC: 6620109. DOI: 10.1053/j.ajkd.2019.01.001. View

11.

Kreis H, Oberbauer R, Campistol J, Mathew T, Daloze P, Schena F . Long-term benefits with sirolimus-based therapy after early cyclosporine withdrawal. J Am Soc Nephrol. 2004; 15(3):809-17. DOI: 10.1097/01.asn.0000113248.59077.76. View

12.

Karim A, Farrugia D, Cheshire J, Mahboob S, Begaj I, Ray D . Recipient age and risk for mortality after kidney transplantation in England. Transplantation. 2013; 97(8):832-8. DOI: 10.1097/01.TP.0000438026.03958.7b. View

13.

Pascual J, Zamora J, Galeano C, Royuela A, Quereda C . Steroid avoidance or withdrawal for kidney transplant recipients. Cochrane Database Syst Rev. 2009; (1):CD005632. DOI: 10.1002/14651858.CD005632.pub2. View

14.

Dharnidharka V, Schnitzler M, Chen J, Brennan D, Axelrod D, Segev D . Differential risks for adverse outcomes 3 years after kidney transplantation based on initial immunosuppression regimen: a national study. Transpl Int. 2016; 29(11):1226-1236. PMC: 5114846. DOI: 10.1111/tri.12850. View

15.

Shah T, Kasravi A, Huang E, Hayashi R, Young B, Cho Y . Risk factors for development of new-onset diabetes mellitus after kidney transplantation. Transplantation. 2007; 82(12):1673-6. DOI: 10.1097/01.tp.0000250756.66348.9a. View

16.

Gill J, Sampaio M, Gill J, Dong J, Kuo H, Danovitch G . Induction immunosuppressive therapy in the elderly kidney transplant recipient in the United States. Clin J Am Soc Nephrol. 2011; 6(5):1168-78. PMC: 3087785. DOI: 10.2215/CJN.07540810. View

17.

Gavazzi G, Krause K . Ageing and infection. Lancet Infect Dis. 2002; 2(11):659-66. DOI: 10.1016/s1473-3099(02)00437-1. View

18.

Johnson D, Herzig K, Purdie D, Brown A, Rigby R, Nicol D . A comparison of the effects of dialysis and renal transplantation on the survival of older uremic patients. Transplantation. 2001; 69(5):794-9. DOI: 10.1097/00007890-200003150-00020. View

19.

Lemoine M, Titeca Beauport D, Lobbedez T, Choukroun G, Hurault de Ligny B, Hazzan M . Risk Factors for Early Graft Failure and Death After Kidney Transplantation in Recipients Older Than 70 Years. Kidney Int Rep. 2019; 4(5):656-666. PMC: 6506713. DOI: 10.1016/j.ekir.2019.01.014. View

20.

Danovitch G, Gill J, Bunnapradist S . Immunosuppression of the elderly kidney transplant recipient. Transplantation. 2007; 84(3):285-91. DOI: 10.1097/01.tp.0000275423.69689.dc. View